BioXcel Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 324,253 | 0.876% |
Hedge Funds | 3,699,749 | 9.99% |
Private Companies | 8,560,586 | 23.1% |
Institutions | 9,670,046 | 26.1% |
General Public | 14,779,883 | 39.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,546,750 | US$21.5m | 0% | no data | |||
3,699,749 | US$9.3m | 0% | 0.24% | |||
2,518,564 | US$6.3m | -6.74% | no data | |||
1,374,209 | US$3.4m | 5.9% | no data | |||
1,089,463 | US$2.7m | -10.7% | no data | |||
541,064 | US$1.4m | -19.1% | no data | |||
465,381 | US$1.2m | 133% | no data | |||
450,227 | US$1.1m | 6.41% | no data | |||
440,332 | US$1.1m | 7.44% | no data | |||
301,735 | US$757.4k | 0% | 0.01% | |||
232,597 | US$583.8k | 0% | no data | |||
225,389 | US$565.7k | -0.12% | no data | |||
187,510 | US$470.6k | 0% | no data | |||
184,375 | US$462.8k | 0% | 100.0% | |||
144,720 | US$363.2k | 19.9% | no data | |||
123,077 | US$308.9k | -2.71% | no data | |||
109,200 | US$274.1k | 0% | 0.02% | |||
87,951 | US$220.8k | -40.3% | no data | |||
83,900 | US$210.6k | 0% | 0.06% | |||
72,572 | US$182.2k | 2.42% | no data | |||
70,000 | US$175.7k | 0% | 0.02% | |||
69,768 | US$175.1k | 4.41% | no data | |||
59,514 | US$149.4k | 0% | 0.01% | |||
57,084 | US$143.3k | 0% | no data | |||
50,250 | US$126.1k | 26.9% | no data |